Heart Failure Reviews

, Volume 13, Issue 2, pp 163–173 | Cite as

Noninvasive imaging of apoptosis in cardiovascular disease

  • Ethan Chauncey Korngold
  • Farouc Amin Jaffer
  • Ralph Weissleder
  • David Edwin Sosnovik
Article

Abstract

Recent advances in molecular imaging have permitted the noninvasive imaging of apoptosis, a critical process underlying the pathogenesis of many diseases of the cardiovascular system including atherosclerotic vascular disease, myocardial ischemia and reperfusion injury, chronic heart failure, myocarditis, and cardiac allograft rejection. Multiple molecular targets including phosphatidylserine, phosphatidylinositol 3-kinase, and caspases have been targeted by a variety of imaging agents and modalities such as nuclear scintigraphy, PET, MRI, and fluorescent and bioluminescent imaging. Translationally, methods utilizing radiolabeled annexin V have proven promising in several clinical trials of ischemia-reperfusion injury and cardiac allograft rejection. New approaches using novel molecular imaging agents show great potential for the ability to image apoptosis in the research and clinical setting. Ultimately the ability to detect apoptosis noninvasively would help to identify patients for emerging anti-apoptotic therapies and guide clinical management with the aim of maximal myocardial preservation.

Keywords

Noninvasive imaging Molecular imaging Apoptosis Cardiovascular Annexin 

References

  1. 1.
    Jaffer FA, Weissleder R (2005) Molecular imaging in the clinical arena. JAMA 293(7):855–862PubMedCrossRefGoogle Scholar
  2. 2.
    Sosnovik DE, Weissleder R (2006) Emerging concepts in molecular MRI. Curr Opin BiotechnolGoogle Scholar
  3. 3.
    Weissleder R (2006) Molecular imaging in cancer. Science 312(5777):1168–1171PubMedCrossRefGoogle Scholar
  4. 4.
    Jaffer FA, Weissleder R (2004) Seeing within: molecular imaging of the cardiovascular system. Circ Res 94(4):433–445PubMedCrossRefGoogle Scholar
  5. 5.
    Narula J, Kietselaer B, Hofstra L (2004) Role of molecular imaging in defining and denying death. J Nucl Cardiol 11(3):349–357PubMedCrossRefGoogle Scholar
  6. 6.
    Chang GY, Xie X, Wu JC (2006) Overview of stem cells and imaging modalities for cardiovascular diseases. J Nucl Cardiol 13(4):554–569PubMedCrossRefGoogle Scholar
  7. 7.
    Jaffer FA, Libby P, Weissleder R (2006) Molecular and cellular imaging of atherosclerosis: emerging applications. J Am Coll Cardiol 47(7):1328–1338PubMedCrossRefGoogle Scholar
  8. 8.
    Jaffer FA, Sosnovik DE, Nahrendorf M, Weissleder R (2006) Molecular imaging of myocardial infarction. J Mol Cell Cardiol 41(6):921–933PubMedCrossRefGoogle Scholar
  9. 9.
    Wickline SA, Neubauer AM, Winter P, Caruthers S, Lanza G (2006) Applications of nanotechnology to atherosclerosis, thrombosis, and vascular biology. Artherioscler Thromb Vasc Biol 26(3):435–441CrossRefGoogle Scholar
  10. 10.
    Danial NN, Korsmeyer SJ (2004) Cell death: critical control points. Cell 116(2):205–219PubMedCrossRefGoogle Scholar
  11. 11.
    Kang PM, Izumo S (2003) Apoptosis in heart: basic mechanisms and implications in cardiovascular diseases. Trends Mol Med 9(4):177–182PubMedCrossRefGoogle Scholar
  12. 12.
    Newmeyer DD, Ferguson-Miller S (2003) Mitochondria: releasing power for life and unleashing the machineries of death. Cell 112(4):481–490PubMedCrossRefGoogle Scholar
  13. 13.
    Foo RS, Mani K, Kitsis RN (2005) Death begets failure in the heart. J Clin Invest 115(3):565–571PubMedCrossRefGoogle Scholar
  14. 14.
    Brauer M (2003) In vivo monitoring of apoptosis. Prog Neuropsychopharmacol Biol Psychiatr 27(2):323–331CrossRefGoogle Scholar
  15. 15.
    Hatano E, Bradham CA, Stark A, Iimuro Y, Lemasters JJ, Brenner DA (2000) The mitochondrial permeability transition augments Fas-induced apoptosis in mouse hepatocytes. J Biol Chem 275(16):11814–11823PubMedCrossRefGoogle Scholar
  16. 16.
    Blankenberg FG, Katsikis PD, Tait JF, Davis RE, Naumovski L, Ohtsuki K, Kopiwoda S, Abrams MJ, Darkes M, Robbins RC, Maecker HT, Strauss HW (1998) In vivo detection and imaging of phosphatidylserine expression during programmed cell death. Proc Natl Acad Sci USA 95(11):6349–6354PubMedCrossRefGoogle Scholar
  17. 17.
    Blankenberg FG, Katsikis PD, Tait JF, Davis RE, Naumovski L, Ohtsuki K, Kopiwoda S, Abrams MJ, Strauss HW (1999) Imaging of apoptosis (programmed cell death) with 99mTc annexin V. J Nucl Med 40(1):184–191PubMedGoogle Scholar
  18. 18.
    Hofstra L, Liem IH, Dumont EA, Boersma HH, van Heerde WL, Doevendans PA, De Muinck E, Wellens HJ, Kemerink GJ, Reutelingsperger CP, Heidendal GA (2000) Visualisation of cell death in vivo in patients with acute myocardial infarction. Lancet 356(9225):209–212PubMedCrossRefGoogle Scholar
  19. 19.
    Kown MH, Strauss HW, Blankenberg FG, Berry GJ, Stafford-Cecil S, Tait JF, Goris ML, Robbins RC (2001) In vivo imaging of acute cardiac rejection in human patients using (99 m)technetium labeled annexin V. Am J Transplant 1(3):270–277PubMedCrossRefGoogle Scholar
  20. 20.
    Narula J, Acio ER, Narula N, Samuels LE, Fyfe B, Wood D, Fitzpatrick JM, Raghunath PN, Tomaszewski JE, Kelly C, Steinmetz N, Green A, Tait JF, Leppo J, Blankenberg FG, Jain D, Strauss HW (2001) Annexin-V imaging for noninvasive detection of cardiac allograft rejection. Nat Med 7(12):1347–1352PubMedCrossRefGoogle Scholar
  21. 21.
    Thimister PW, Hofstra L, Liem IH, Boersma HH, Kemerink G, Reutelingsperger CP, Heidendal GA (2003) In vivo detection of cell death in the area at risk in acute myocardial infarction. J Nucl Med 44(3):391–396PubMedGoogle Scholar
  22. 22.
    Bennink RJ, van den Hoff MJ, van Hemert FJ, de Bruin KM, Spijkerboer AL, Vanderheyden JL, Steinmetz N, van Eck-Smit BL (2004) Annexin V imaging of acute doxorubicin cardiotoxicity (apoptosis) in rats. J Nucl Med 45(5):842–848PubMedGoogle Scholar
  23. 23.
    Kietselaer BL, Reutelingsperger CP, Heidendal GA, Daemen MJ, Mess WH, Hofstra L, Narula J (2004) Noninvasive detection of plaque instability with use of radiolabeled annexin A5 in patients with carotid-artery atherosclerosis. N Engl J Med 350(14):1472–1473PubMedCrossRefGoogle Scholar
  24. 24.
    Peker C, Sarda-Mantel L, Loiseau P, Rouzet F, Nazneen L, Martet G, Vrigneaud JM, Meulemans A, Saumon G, Michel JB, Le Guludec D (2004) Imaging apoptosis with (99m)Tc-annexin-V in experimental subacute myocarditis. J Nucl Med 45(6):1081–1086PubMedGoogle Scholar
  25. 25.
    Hartung D, Sarai M, Petrov A, Kolodgie F, Narula N, Verjans J, Virmani R, Reutelingsperger C, Hofstra L, Narula J (2005) Resolution of apoptosis in atherosclerotic plaque by dietary modification and statin therapy. J Nucl Med 46(12):2051–2056PubMedGoogle Scholar
  26. 26.
    Johnson LL, Schofield L, Donahay T, Narula N, Narula J (2005) 99mTc-annexin V imaging for in vivo detection of atherosclerotic lesions in porcine coronary arteries. J Nucl Med 46(7):1186–1193PubMedGoogle Scholar
  27. 27.
    Isobe S, Tsimikas S, Zhou J, Fujimoto S, Sarai M, Branks MJ, Fujimoto A, Hofstra L, Reutelingsperger CP, Murohara T, Virmani R, Kolodgie FD, Narula N, Petrov A, Narula J (2006) Noninvasive imaging of atherosclerotic lesions in apolipoprotein E-deficient and low-density-lipoprotein receptor-deficient mice with annexin A5. J Nucl Med 47(9):1497–1505PubMedGoogle Scholar
  28. 28.
    Sarda-Mantel L, Michel JB, Rouzet F, Martet G, Louedec L, Vanderheyden JL, Hervatin F, Raguin O, Vrigneaud JM, Khaw BA, Le Guludec D (2006) (99 m)Tc-annexin V and (111)In-antimyosin antibody uptake in experimental myocardial infarction in rats. Eur J Nucl Med Mol Imaging 33(3):239–245PubMedCrossRefGoogle Scholar
  29. 29.
    Grierson JR, Yagle KJ, Eary JF, Tait JF, Gibson DF, Lewellen B, Link JM, Krohn KA (2004) Production of [F-18]fluoroannexin for imaging apoptosis with PET. Bioconjug Chem 15(2):373–379PubMedCrossRefGoogle Scholar
  30. 30.
    Keen HG, Dekker BA, Disley L, Hastings D, Lyons S, Reader AJ, Ottewell P, Watson A, Zweit J (2005) Imaging apoptosis in vivo using 124I-annexin V and PET. Nucl Med Biol 32(4):395–402PubMedCrossRefGoogle Scholar
  31. 31.
    Cauchon N, Langlois R, Rousseau JA, Tessier G, Cadorette J, Lecomte R, Hunting DJ, Pavan RA, Zeisler SK, van Lier JE (2006) PET imaging of apoptosis with (64)Cu-labeled streptavidin following pretargeting of phosphatidylserine with biotinylated annexin-V. Eur J Nucl Med Mol ImagingGoogle Scholar
  32. 32.
    Sosnovik DE, Schellenberger EA, Nahrendorf M, Novikov MS, Matsui T, Dai G, Reynolds F, Grazette L, Rosenzweig A, Weissleder R, Josephson L (2005) Magnetic resonance imaging of cardiomyocyte apoptosis with a novel magneto-optical nanoparticle. Magn Reson Med 54(3):718–724PubMedCrossRefGoogle Scholar
  33. 33.
    Hiller KH, Waller C, Nahrendorf M, Bauer WR, Jakob PM (2006) Assessment of cardiovascular apoptosis in the isolated rat heart by magnetic resonance molecular imaging. Mol Imaging 5(2):115–121PubMedGoogle Scholar
  34. 34.
    Petrovsky A, Schellenberger E, Josephson L, Weissleder R, Bogdanov A Jr (2003) Near-infrared fluorescent imaging of tumor apoptosis. Cancer Res 63(8):1936–1942PubMedGoogle Scholar
  35. 35.
    Ntziachristos V, Schellenberger EA, Ripoll J, Yessayan D, Graves E, Bogdanov A Jr, Josephson L, Weissleder R (2004) Visualization of antitumor treatment by means of fluorescence molecular tomography with an annexin V-Cy5.5 conjugate. Proc Natl Acad Sci USA 101(33):12294–12299PubMedCrossRefGoogle Scholar
  36. 36.
    Zhao M, Zhu X, Ji S, Zhou J, Ozker KS, Fang W, Molthen RC, Hellman RS (2006) 99mTc-labeled C2A domain of synaptotagmin I as a target-specific molecular probe for noninvasive imaging of acute myocardial infarction. J Nucl Med 47(8):1367–1374PubMedGoogle Scholar
  37. 37.
    Zhao M, Beauregard DA, Loizou L, Davletov B, Brindle KM (2001) Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent. Nat Med 7(11):1241–1244PubMedCrossRefGoogle Scholar
  38. 38.
    Zhou D, Chu W, Rothfuss J, Zeng C, Xu J, Jones L, Welch MJ, Mach RH (2006) Synthesis, radiolabeling, and in vivo evaluation of an 18F-labeled isatin analog for imaging caspase-3 activation in apoptosis. Bioorg Med Chem Lett 16(19):5041–5046PubMedCrossRefGoogle Scholar
  39. 39.
    Messerli SM, Prabhakar S, Tang Y, Shah K, Cortes ML, Murthy V, Weissleder R, Breakefield XO, Tung CH (2004) A novel method for imaging apoptosis using a caspase-1 near-infrared fluorescent probe. Neoplasia 6(2):95–105PubMedCrossRefGoogle Scholar
  40. 40.
    Laxman B, Hall DE, Bhojani MS, Hamstra DA, Chenevert TL, Ross BD, Rehemtulla A (2002) Noninvasive real-time imaging of apoptosis. Proc Natl Acad Sci USA 99(26):16551–16555PubMedCrossRefGoogle Scholar
  41. 41.
    Fadok VA, Savill JS, Haslett C, Bratton DL, Doherty DE, Campbell PA, Henson PM (1992) Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognize and remove apoptotic cells. J Immunol 149(12):4029–4035PubMedGoogle Scholar
  42. 42.
    van Heerde WL, Robert-Offerman S, Dumont E, Hofstra L, Doevendans PA, Smits JF, Daemen MJ, Reutelingsperger CP (2000) Markers of apoptosis in cardiovascular tissues: focus on Annexin V. Cardiovasc Res 45(3):549–559PubMedCrossRefGoogle Scholar
  43. 43.
    Schellenberger EA, Sosnovik D, Weissleder R, Josephson L (2004) Magneto/optical annexin V, a multimodal protein. Bioconjug Chem 15(5):1062–1067PubMedCrossRefGoogle Scholar
  44. 44.
    Davletov BA, Sudhof TC (1993) A single C2 domain from synaptotagmin I is sufficient for high affinity Ca2+/phospholipid binding. J Biol Chem 268(35):26386–26390PubMedGoogle Scholar
  45. 45.
    Schellenberger EA, Reynolds F, Weissleder R, Josephson L (2004) Surface-functionalized nanoparticle library yields probes for apoptotic cells. Chembiochem 5(3):275–279PubMedCrossRefGoogle Scholar
  46. 46.
    Quinti L, Weissleder R, Tung CH (2006) A fluorescent nanosensor for apoptotic cells. Nano Lett 6(3):488–490PubMedCrossRefGoogle Scholar
  47. 47.
    Aloya R, Shirvan A, Grimberg H, Reshef A, Levin G, Kidron D, Cohen A, Ziv I (2006) Molecular imaging of cell death in vivo by a novel small molecule probe. Apoptosis 11(12):2089–2101PubMedCrossRefGoogle Scholar
  48. 48.
    Fujio Y, Nguyen T, Wencker D, Kitsis RN, Walsh K (2000) Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation 101(6):660–667PubMedGoogle Scholar
  49. 49.
    Wymann MP, Bulgarelli-Leva G, Zvelebil MJ, Pirola L, Vanhaesebroeck B, Waterfield MD, Panayotou G (1996) Wortmannin inactivates phosphoinositide 3-kinase by covalent modification of Lys-802, a residue involved in the phosphate transfer reaction. Mol Cell Biol 16(4):1722–1733PubMedGoogle Scholar
  50. 50.
    Yuan H, Luo J, Field S, Weissleder R, Cantley L, Josephson L (2005) Synthesis and activity of C11-modified wortmannin probes for PI3 kinase. Bioconjug Chem 16(3):669–675PubMedCrossRefGoogle Scholar
  51. 51.
    Gross S, Piwnica-Worms D (2005) Spying on cancer: molecular imaging in vivo with genetically encoded reporters. Cancer Cell 7(1):5–15PubMedGoogle Scholar
  52. 52.
    Bhojani MS, Hamstra DA, Chang DC, Coppola JM, Khan AP, Reddy GR, Ross BD, Rehemtulla A (2006) Imaging of proteolytic activity using a conditional cell surface receptor. Mol Imaging 5(2):129–137PubMedGoogle Scholar
  53. 53.
    Lin J, Zhang Z, Yang J, Zeng S, Liu BF, Luo Q (2006) Real-time detection of caspase-2 activation in a single living HeLa cell during cisplatin-induced apoptosis. J Biomed Opt 11(4):049801CrossRefGoogle Scholar
  54. 54.
    Kim K, Lee M, Park H, Kim JH, Kim S, Chung H, Choi K, Kim IS, Seong BL, Kwon IC (2006) Cell-permeable and biocompatible polymeric nanoparticles for apoptosis imaging. J Am Chem Soc 128(11):3490–3491PubMedCrossRefGoogle Scholar
  55. 55.
    Liu JJ, Wang W, Dicker DT, El-Deiry WS (2005) Bioluminescent imaging of TRAIL-induced apoptosis through detection of caspase activation following cleavage of DEVD-aminoluciferin. Cancer Biol Ther 4(8):885–892PubMedCrossRefGoogle Scholar
  56. 56.
    Stefflova K, Chen J, Li H, Zheng G (2006) Targeted photodynamic therapy agent with a built-in apoptosis sensor for in vivo near-infrared imaging of tumor apoptosis triggered by its photosensitization in situ. Mol Imaging 5(4):520–532PubMedGoogle Scholar
  57. 57.
    Bauer C, Bauder-Wuest U, Mier W, Haberkorn U, Eisenhut M (2005) 131I-labeled peptides as caspase substrates for apoptosis imaging. J Nucl Med 46(6):1066–1074PubMedGoogle Scholar
  58. 58.
    Ramlawi B, Feng J, Mieno S, Szabo C, Zsengeller Z, Clements R, Sodha N, Boodhwani M, Bianchi C, Sellke FW (2006) Indices of apoptosis activation after blood cardioplegia and cardiopulmonary bypass. Circulation 114(1 Suppl):I257–I263PubMedGoogle Scholar
  59. 59.
    Rossi ML, Marziliano N, Merlini PA, Bramucci E, Canosi U, Belli G, Parenti DZ, Mannucci PM, Ardissino D (2004) Different quantitative apoptotic traits in coronary atherosclerotic plaques from patients with stable angina pectoris and acute coronary syndromes. Circulation 110(13):1767–1773PubMedCrossRefGoogle Scholar
  60. 60.
    Kockx MM, Knaapen MW (2006) Pathological changes in the coronary arteries in the acute coronary syndromes. Heart 92(11):1557–1558PubMedCrossRefGoogle Scholar
  61. 61.
    Bjorkerud S, Bjorkerud B (1996) Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability. Am J Pathol 149(2):367–380PubMedGoogle Scholar
  62. 62.
    Libby P (2002) Inflammation in atherosclerosis. Nature 420(6917):868–874PubMedCrossRefGoogle Scholar
  63. 63.
    Kolodgie FD, Petrov A, Virmani R, Narula N, Verjans JW, Weber DK, Hartung D, Steinmetz N, Vanderheyden JL, Vannan MA, Gold HK, Reutelingsperger CP, Hofstra L, Narula J (2003) Targeting of apoptotic macrophages and experimental atheroma with radiolabeled annexin V: a technique with potential for noninvasive imaging of vulnerable plaque. Circulation 108(25):3134–3139PubMedCrossRefGoogle Scholar
  64. 64.
    Bolli R, Becker L, Gross G, Mentzer R Jr, Balshaw D, Lathrop DA (2004) Myocardial protection at a crossroads: the need for translation into clinical therapy. Circ Res 95(2):125–134PubMedCrossRefGoogle Scholar
  65. 65.
    Anversa P, Cheng W, Liu Y, Leri A, Redaelli G, Kajstura J (1998) Apoptosis and myocardial infarction. Basic Res Cardiol 93 (Suppl 3):8–12PubMedCrossRefGoogle Scholar
  66. 66.
    Olivetti G, Quaini F, Sala R, Lagrasta C, Corradi D, Bonacina E, Gambert SR, Cigola E, Anversa P (1996) Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart. J Mol Cell Cardiol 28(9):2005–2016PubMedCrossRefGoogle Scholar
  67. 67.
    Gottlieb RA, Burleson KO, Kloner RA, Babior BM, Engler RL (1994) Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 94(4):1621–1628PubMedCrossRefGoogle Scholar
  68. 68.
    Garg S, Hofstra L, Reutelingsperger C, Narula J (2003) Apoptosis as a therapeutic target in acutely ischemic myocardium. Curr Opin Cardiol 18(5):372–377PubMedCrossRefGoogle Scholar
  69. 69.
    Dumont EA, Reutelingsperger CP, Smits JF, Daemen MJ, Doevendans PA, Wellens HJ, Hofstra L (2001) Real-time imaging of apoptotic cell-membrane changes at the single-cell level in the beating murine heart. Nat Med 7(12):1352–1355PubMedCrossRefGoogle Scholar
  70. 70.
    Taki J, Higuchi T, Kawashima A, Tait JF, Kinuya S, Muramori A, Matsunari I, Nakajima K, Tonami N, Strauss HW (2004) Detection of cardiomyocyte death in a rat model of ischemia and reperfusion using 99mTc-labeled annexin V. J Nucl Med 45(9):1536–1541PubMedGoogle Scholar
  71. 71.
    Dumont EA, Hofstra L, van Heerde WL, van den Eijnde S, Doevendans PA, DeMuinck E, Daemen MA, Smits JF, Frederik P, Wellens HJ, Daemen MJ, Reutelingsperger CP (2000) Cardiomyocyte death induced by myocardial ischemia and reperfusion: measurement with recombinant human annexin-V in a mouse model. Circulation 102(13):1564–1568PubMedGoogle Scholar
  72. 72.
    Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara JA, Quaini E, Di Loreto C, Beltrami CA, Krajewski S, Reed JC, Anversa P (1997) Apoptosis in the failing human heart. N Engl J Med 336(16):1131–1141PubMedCrossRefGoogle Scholar
  73. 73.
    Guerra S, Leri A, Wang X, Finato N, Di Loreto C, Beltrami CA, Kajstura J, Anversa P (1999) Myocyte death in the failing human heart is gender dependent. Circ Res 85(9):856–866PubMedGoogle Scholar
  74. 74.
    Saraste A, Pulkki K, Kallajoki M, Heikkila P, Laine P, Mattila S, Nieminen MS, Parvinen M, Voipio-Pulkki LM (1999) Cardiomyocyte apoptosis and progression of heart failure to transplantation. Eur J Clin Invest 29(5):380–386PubMedCrossRefGoogle Scholar
  75. 75.
    Hayakawa Y, Chandra M, Miao W, Shirani J, Brown JH, Dorn GW 2nd, Armstrong RC, Kitsis RN (2003) Inhibition of cardiac myocyte apoptosis improves cardiac function and abolishes mortality in the peripartum cardiomyopathy of Galpha(q) transgenic mice. Circulation 108(24):3036–3041PubMedCrossRefGoogle Scholar
  76. 76.
    Adams JW, Sakata Y, Davis MG, Sah VP, Wang Y, Liggett SB, Chien KR, Brown JH, Dorn GW 2nd (1998) Enhanced Galphaq signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure. Proc Natl Acad Sci USA 95(17):10140–10145PubMedCrossRefGoogle Scholar
  77. 77.
    Sosnovik D, Nahrendorf M, Grazette L, Reynolds F, Rosenzweig A, Weissleder R, Josephson L (2005) Molecular imaging of low levels of cardiomyocyte apoptosis with a targeted magneto-fluorescent contrast agent. In: American Heart Association Scientific Sessions Series. Molecular imaging of low levels of cardiomyocyte apoptosis with a targeted magneto-fluorescent contrast agentGoogle Scholar
  78. 78.
    Petillot P, Lahorte C, Bonanno E, Signore A, Lancel S, Marchetti P, Vallet B, Slegers G, Neviere R (2007) Annexin V detection of lipopolysaccharide-induced cardiac apoptosis. Shock 27(1):69–74PubMedCrossRefGoogle Scholar
  79. 79.
    Yeh ET, Tong AT, Lenihan DJ, Yusuf SW, Swafford J, Champion C, Durand JB, Gibbs H, Zafarmand AA, Ewer MS (2004) Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management. Circulation 109(25):3122–3131PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Ethan Chauncey Korngold
    • 1
    • 2
  • Farouc Amin Jaffer
    • 1
    • 2
  • Ralph Weissleder
    • 1
  • David Edwin Sosnovik
    • 1
    • 2
  1. 1.Center for Molecular Imaging ResearchMassachusetts General Hospital, Harvard Medical SchoolBostonUSA
  2. 2.Cardiology Division, Department of MedicineMassachusetts General Hospital, Harvard Medical SchoolBostonUSA

Personalised recommendations